Three years of tirzepatide also reduced risk for progression to type 2 diabetes compared with placebo
Global Coverage With Measles Vaccine Declined During COVID-19
From 2022 to 2023, there was a 20 percent increase in estimated measles cases worldwide, from 8,645,000 to 10,341,000